TerminatedNot applicableNCT00737724

Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment

Studying Acquired immunodeficiency

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Instituto Nacional de Enfermedades Respiratorias
Principal Investigator
Gustavo Reyes-Terán, MD, LMFT
Instituto Nacional de Enfermedades Respiratorias
Intervention
Simultaneous ARV and antiMTB(drug)
Enrollment
63 enrolled
Eligibility
18-60 years · All sexes
Timeline
20082011

Study locations (2)

Collaborators

Consorcio de Investigación sobre VIH/SIDA/TB (CISIDAT).

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00737724 on ClinicalTrials.gov

Other trials for Acquired immunodeficiency

Additional recruiting or active studies for the same condition.

See all trials for Acquired immunodeficiency

← Back to all trials